This contract expires in 348 days (Mar 31, 2027).
FIRM FIXED PRICE
BAYER HEALTHCARE PHARMACEUTICALS INC - XOFIGO - RADIUM RA 223DICHLORIDE INJ
PIID: 36C26226F0163
Signed Date: Feb 25, 2026Effective Date: Apr 1, 2026End Date: Closes in 348 days
Key Details
Description
XOFIGO - RADIUM RA 223DICHLORIDE INJ
Contractor Information
Contractor: BAYER HEALTHCARE PHARMACEUTICALS INC
UEI: V1EVGCK7XES8
CAGE Code: 59463
Location: WHIPPANY, NJ
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.